9 results
IDSA 2017 CDiff Guidelines - Table 7. Potential Treatment Agents for Treatment of the Primary Clostridium difficile
IDSA 2017 CDiff ... Guidelines - Table ... #Pharmacology #Management ... #CDifficile #IDSA2017 ... #Adjunct #Antibiotics
Specific antibiotic in-hospital treatment for community-acquired bacterial meningitis

#bacterial #meningitis #management #antibiotics #therapy #treatment #table #duration #empiric
Specific antibiotic ... in-hospital treatment ... for community-acquired ... bacterial #meningitis #management ... #treatment #table
IDSA 2017 CDiff Guidelines - Table 1. Recommendations for the Treatment of Clostridium difficile Infection in Adults

#Management
IDSA 2017 CDiff ... Guidelines - Table ... Recommendations for the Treatment ... Infection in Adults #Management ... #Clostridium #CDifficile
IDSA 2017 CDiff Guidelines - Table 2. Recommendations for the Treatment of Clostridium difficile Infection in Children

#Management
IDSA 2017 CDiff ... Guidelines - Table ... Recommendations for the Treatment ... in Children #Management ... #Clostridium #CDifficile
C.diff - Clostridioides Difficile Infection (CDI) - Diagnosis and Management - GrepMed Handbook

Clinical Presentation + Progression:
Diagnosis and Management ... Toxic Megacolon, Shock ... can be community-acquired ... Ileus, Megacolon, Shock ... ciab549 #CDI #Cdiff
Causes of Antibiotic Failure - Differential Diagnosis Framework
Diagnosis:
 • Non-Infectious: Malignant, Autoimmune, Drug-related (NMS, serotonin syndrome,
Immunocompromise Treatment ... • Secondary to Treatment ... Secondary infection (C diff ... ) • Hospital-Acquired ... Difficile, COVID
Antibiotics for Anaerobic Bacteria 
 - Metronidazole (Flagyl™) 
 - Carbapenems 
 - β lactam +
Antibiotics for ... out of favor for treatment ... out of favor for C.diff ... #Pharmacology #Table ... Susceptibility #Coverage #Management
Potential Treatment Agents for Treatment of the Primary Clostridium difficile infection Episode
Proven efficacy:
 • Vancomycin -
Potential Treatment ... Primary Clostridium difficile ... × 10 days #CDiff ... #management #pharmacology ... #idsa #table
IDSA - Approach to Treating a Patient With Diabetic Foot Osteomyelitis
When to consider a trial of
of nonsurgical treatment ... 48–72 h if on treatment ... high risk for C. difficile ... not otherwise required ... #nonoperative #management